Forbion European Acquisition Corp.

Forbion European Acquisition Corp. (ticker: FRBN) is a blank-check company sponsored by Forbion Capital Partners, a Netherlands-based venture capital firm with a long-established focus on life sciences and healthcare investment. The SPAC completed its initial public offering in 2021 and is targeting acquisition opportunities within the European biotechnology and life sciences sector. As of its 10-Q filing dated May 12, 2023, the company remained in the process of identifying and evaluating a business combination target, continuing its search within the healthcare and biopharmaceutical space. Investors and analysts looking for comprehensive filing data, deal timelines, and status tracking for FRBN can sign up for full access at SpacDesk.